| Literature DB >> 16277683 |
Berit Sverdrup1, Henrik Källberg, Camilla Bengtsson, Ingvar Lundberg, Leonid Padyukov, Lars Alfredsson, Lars Klareskog.
Abstract
The aim of the present study was to investigate the association between exposure to mineral oil and the risk of developing rheumatoid arthritis (RA), and in addition to perform a separate analysis on the major subphenotypes for the disease; namely, rheumatoid factor (RF)-positive RA, RF-negative RA, anticitrulline-positive RA and anticitrulline-negative RA, respectively. A population-based case-control study of incident cases of RA was performed among the population aged 18-70 years in a defined area of Sweden during May 1996-December 2003. A case was defined as an individual from the study base who for the first time received a diagnosis of RA according to the American College of Rheumatology criteria of 1987. Controls were randomly selected from the study base with consideration taken for age, gender and residential area. Cases (n = 1,419) and controls (n = 1,674) answered an extensive questionnaire regarding lifestyle factors and occupational exposures, including different types of mineral oils. Sera from cases and controls were investigated for RF and anticitrulline antibodies. Among men, exposure to any mineral oil was associated with a 30% increased relative risk of developing RA (relative risk = 1.3, 95% confidence interval = 1.0-1.7). When cases were subdivided into RF-positive RA and RF-negative RA, an increased risk was only observed for RF-positive RA (relative risk = 1.4, 95% confidence interval 1.0-2.0). When RA cases were subdivided according to the presence of anticitrulline antibodies, an increased risk associated with exposure to any mineral oil was observed only for anticitrulline-positive RA (relative risk = 1.6, 95% confidence interval = 1.1-2.2). Analysis of the interaction between oil exposure and the presence of HLA-DR shared epitope genes regarding the incidence of RA indicated that the increased risk associated with exposure to mineral oil was not related to the presence of shared epitope genotypes. In conclusion, our study shows that exposure to mineral oil is associated with an increased risk to develop RF-positive RA and anticitrulline-positive RA, respectively. The findings are of particular interest since the same mineral oils can induce polyarthritis in rats.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16277683 PMCID: PMC1297574 DOI: 10.1186/ar1824
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Relative risk for developing RF-positive or RF-negative RA in men exposed to mineral oils
| Outcome | Oil | Exposed cases/controls ( | Relative riskb | 95% confidence interval | Relative riskc | 95% confidence interval |
| Total RA | Cutting fluid | 36/39 | 1.1 | 0.7–1.9 | 1.1 | 0.7–1.8 |
| Motor oil | 84/84 | 1.2 | 0.9–1.8 | 1.2 | 0.9–1.8 | |
| Hydraulic oil | 83/72 | 1.4 | 1.0–2.1 | 1.4 | 1.0–2.0 | |
| Form oil | 25/24 | 1.3 | 0.7–2.5 | 1.3 | 0.7–2.4 | |
| Asphalt | 13/14 | 1.3 | 0.6–2.8 | 1.2 | 0.6–2.7 | |
| Any mineral oil | 135/132 | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.7 | |
| RF+ RA | Cutting fluid | 29/39 | 1.4 | 0.8–2.5 | 1.4 | 0.8–2.4 |
| Motor oil | 60/84 | 1.4 | 0.9–2.1 | 1.4 | 0.9–2.1 | |
| Hydraulic oil | 56/72 | 1.6 | 1.0–2.3 | 1.5 | 1.0–2.3 | |
| Form oil | 20/24 | 1.7 | 0.9–3.3 | 1.7 | 0.9–3.2 | |
| Asphalt | 9/14 | 1.4 | 0.6–3.5 | 1.4 | 0.6–3.4 | |
| Any mineral oil | 96/132 | 1.5 | 1.0–2.0 | 1.4 | 1.0–2.0 | |
| RF- RA | Cutting fluid | 7/39 | 0.6 | 0.2–1.4 | 0.6 | 0.2–1.4 |
| Motor oil | 24/84 | 0.9 | 0.6–1.6 | 0.9 | 0.5–1.6 | |
| Hydraulic oil | 27/72 | 1.2 | 0.7–2.1 | 1.2 | 0.7–2.1 | |
| Form oil | 5/24 | 0.6 | 0.2–1.8 | 0.6 | 0.2–1.8 | |
| Asphalt | 4/14 | 0.9 | 0.3–3.0 | 0.9 | 0.3–3.0 | |
| Any mineral oil | 39/132 | 1.0 | 0.6–1.5 | 1.0 | 0.6–1.5 |
Relative risk and 95% confidence interval for developing rheumatoid factor (RF)-positive rheumatoid arthritis (RA), RF- RA and RA overall (total RA) for men 18–70 years old exposed to different kinds of mineral oils compared with unexposed men.
aRF status unknown for one unexposed case.
bAdjusted for age and residential area.
cAdjusted for age, residential area and smoking.
Relative risk for developing anti-CP-positive RA or anti-CP-negative RA for men exposed to mineral oils
| Outcome | Oil | Exposed cases/controls ( | Relative riska | 95% confidence interval | Relative riskb | 95% confidence interval |
| Anti-CP+ RA | Cutting fluid | 28/39 | 1.6 | 0.9–2.7 | 1.5 | 0.8–2.6 |
| Motor oil | 57/84 | 1.5 | 1.0–2.2 | 1.5 | 1.0–2.3 | |
| Hydraulic oil | 56/72 | 1.8 | 1.2–2.7 | 1.7 | 1.1–2.6 | |
| Form oil | 16/24 | 1.5 | 0.7–2.9 | 1.4 | 0.7–2.9 | |
| Asphalt | 10/14 | 1.6 | 0.7–3.9 | 1.5 | 0.6–3.7 | |
| Any mineral oil | 93/132 | 1.6 | 1.1–2.2 | 1.6 | 1.1–2.2 | |
| Anti-CP- RA | Cutting fluid | 8/39 | 0.6 | 0.2–1.3 | 0.6 | 0.2–1.3 |
| Motor oil | 27/84 | 0.9 | 0.6–1.5 | 0.9 | 0.6–1.5 | |
| Hydraulic oil | 27/72 | 1.0 | 0.6–1.7 | 1.0 | 0.6–1.7 | |
| Form oil | 9/24 | 1.1 | 0.5–2.6 | 1.1 | 0.5–2.6 | |
| Asphalt | 3/14 | 0.7 | 0.2–2.6 | 0.7 | 0.2–2.6 | |
| Any mineral oil | 42/132 | 1.0 | 0.6–1.5 | 1.0 | 0.6–1.5 |
Relative risk and 95% confidence interval for developing antibodies to citrulline-containing peptides (anti-CP)-positive rheumatoid arthritis (RA) and anti-CP- RA for men 18–70 years old exposed to different kinds of mineral oils compared with unexposed men.
aAdjusted for age and residential area.
bAdjusted for age, residential area and smoking.
Relative risk for RA with different combinations of mineral oil exposure and shared epitope genes
| Outcome | Exposure to mineral oil | No shared epitope | Any shared epitope | ||||
| Cases/controls ( | Relative riskb | 95% confidence interval | Cases/controls ( | Relative riskb | 95% confidence interval | ||
| RF+ RA | No | 28/89 | 1.0c | 128/88 | 4.7 | 2.8–8.0 | |
| Yes | 17/43 | 1.2 | 0.6–2.5 | 73/38 | 6.4 | 3.4–11.8 | |
| RF- RA | No | 32/89 | 1.0c | 63/88 | 2.1 | 1.2–3.6 | |
| Yes | 10/43 | 0.7 | 0.3–1.5 | 25/38 | 2.1 | 1.1–4.2 | |
| Total RA | No | 60/89 | 1.0c | 191/88 | 3.2 | 2.1–4.9 | |
| Yes | 27/43 | 0.9 | 0.5–1.7 | 98/38 | 3.9 | 2.3–6.6 | |
| Anti-CP+ RA | No | 18/89 | 1.0c | 126/88 | 8.0 | 4.4–14.7 | |
| Yes | 13/43 | 1.6 | 0.7–3.7 | 75/38 | 11.1 | 5.6–22.1 | |
| Anti-CP- RA | No | 42/89 | 1.0c | 65/88 | 1.5 | 0.9–2.5 | |
| Yes | 14/43 | 0.7 | 0.3–1.5 | 23/38 | 1.5 | 0.7–2.9 | |
| Total RA | No | 60/89 | 1.0c | 191/88 | 3.2 | 2.1–4.9 | |
| Yes | 27/43 | 0.9 | 0.5–1.7 | 98/38 | 3.9 | 2.3–6.6 | |
Relative risk and 95% confidence interval for developing rheumatoid factor (RF)-positive rheumatoid arthritis (RA), RF- RA, antibodies to citrulline-containing peptides (anti-CP)-positive RA, anti-CP- RA and total RA for men with different combinations of exposure to mineral oil and shared epitope genes compared with men unexposed to any mineral oil and lacking shared epitope genes.
aData on the shared epitope are missing for 10 cases and 51 controls exposed to mineral oil, and for 21 cases and 176 controls unexposed to mineral oil (in comparison with Tables 1 and 2).
bRelative risk adjusted for age, residential area and smoking.
cReference group.
Figure 1Relative risk of anti-CP-positive RA with mineral exposure and different expression of SE genes. The relative risk (RR) of developing rheumatoid arthritis (RA) positive for antibodies to citrulline-containing peptides (anti-CP) with mineral exposure and shared epitope (SE) genes compared with unexposed subjects with SE genes is 1.4, with 95% confidence interval = 0.8–2.4. The corresponding risk among subjects with no SE gene is 1.5, with 95% confidence interval = 0.6–3.9.